AAA- a further step towards a moratorium for aspirin in the primary prevention.
Minar
E
E
D000368:Aged; D055109:Ankle Brachial Index; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D018570:Risk Assessment; D012606:Scotland / Q000453:epidemiology; D013997:Time Factors; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D001241:Aspirin